Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
3,678.20
-63.70 (-1.70%)
Aug 1, 2025, 3:29 PM IST
Torrent Pharmaceuticals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
118,351 | 115,161 | 107,278 | 96,202 | 85,080 | 80,046 | Upgrade | |
Revenue Growth (YoY) | 7.63% | 7.35% | 11.51% | 13.07% | 6.29% | 0.82% | Upgrade |
Cost of Revenue | 28,559 | 27,759 | 26,862 | 27,352 | 24,420 | 21,464 | Upgrade |
Gross Profit | 89,792 | 87,402 | 80,416 | 68,850 | 60,660 | 58,582 | Upgrade |
Selling, General & Admin | 23,258 | 22,708 | 20,166 | 17,052 | 15,483 | 14,597 | Upgrade |
Other Operating Expenses | 28,044 | 27,484 | 26,573 | 23,377 | 20,865 | 19,184 | Upgrade |
Operating Expenses | 59,291 | 58,141 | 54,693 | 47,449 | 42,967 | 40,354 | Upgrade |
Operating Income | 30,501 | 29,261 | 25,724 | 21,400 | 17,693 | 18,228 | Upgrade |
Interest Expense | -2,324 | -2,514 | -3,526 | -3,322 | -2,529 | -3,508 | Upgrade |
Interest & Investment Income | 201.9 | 201.9 | 114.8 | 147.8 | 71.5 | 50.7 | Upgrade |
Currency Exchange Gain (Loss) | -166.1 | -166.1 | -39.1 | -180.8 | 1,695 | 319.7 | Upgrade |
Other Non Operating Income (Expenses) | -603.1 | 6.9 | 314.4 | 61.1 | 76 | 21.7 | Upgrade |
EBT Excluding Unusual Items | 27,610 | 26,790 | 22,587 | 18,106 | 17,007 | 15,112 | Upgrade |
Merger & Restructuring Charges | - | - | - | - | -4,847 | - | Upgrade |
Gain (Loss) on Sale of Investments | 167.3 | 167.3 | 179.9 | 195.1 | 101.4 | 155.8 | Upgrade |
Gain (Loss) on Sale of Assets | 13.4 | 13.4 | -0.2 | 216.2 | - | - | Upgrade |
Asset Writedown | - | - | -129.7 | -45.6 | -2.3 | -4.8 | Upgrade |
Other Unusual Items | -242.1 | -242.1 | 883.8 | - | - | - | Upgrade |
Pretax Income | 27,548 | 26,728 | 23,521 | 18,472 | 12,259 | 15,263 | Upgrade |
Income Tax Expense | 7,526 | 7,616 | 6,957 | 6,019 | 4,487 | 2,744 | Upgrade |
Earnings From Continuing Operations | 20,023 | 19,113 | 16,564 | 12,452 | 7,772 | 12,519 | Upgrade |
Net Income | 20,023 | 19,113 | 16,564 | 12,452 | 7,772 | 12,519 | Upgrade |
Net Income to Common | 20,023 | 19,113 | 16,564 | 12,452 | 7,772 | 12,519 | Upgrade |
Net Income Growth | 15.38% | 15.39% | 33.02% | 60.22% | -37.92% | 22.17% | Upgrade |
Shares Outstanding (Basic) | 338 | 338 | 338 | 338 | 338 | 338 | Upgrade |
Shares Outstanding (Diluted) | 338 | 338 | 338 | 338 | 338 | 338 | Upgrade |
EPS (Basic) | 59.15 | 56.47 | 48.94 | 36.79 | 22.96 | 36.99 | Upgrade |
EPS (Diluted) | 59.15 | 56.47 | 48.94 | 36.79 | 22.96 | 36.99 | Upgrade |
EPS Growth | 15.37% | 15.39% | 33.02% | 60.22% | -37.92% | 22.17% | Upgrade |
Free Cash Flow | - | 19,732 | 28,333 | 17,942 | 16,004 | 16,702 | Upgrade |
Free Cash Flow Per Share | - | 58.30 | 83.72 | 53.01 | 47.29 | 49.35 | Upgrade |
Dividend Per Share | 32.000 | 32.000 | 28.000 | 22.000 | 16.500 | 17.500 | Upgrade |
Dividend Growth | 14.29% | 14.29% | 27.27% | 33.33% | -5.71% | 105.88% | Upgrade |
Gross Margin | 75.87% | 75.89% | 74.96% | 71.57% | 71.30% | 73.19% | Upgrade |
Operating Margin | 25.77% | 25.41% | 23.98% | 22.25% | 20.80% | 22.77% | Upgrade |
Profit Margin | 16.92% | 16.60% | 15.44% | 12.94% | 9.13% | 15.64% | Upgrade |
Free Cash Flow Margin | - | 17.14% | 26.41% | 18.65% | 18.81% | 20.87% | Upgrade |
EBITDA | 37,991 | 36,758 | 33,249 | 28,026 | 23,823 | 24,291 | Upgrade |
EBITDA Margin | 32.10% | 31.92% | 30.99% | 29.13% | 28.00% | 30.35% | Upgrade |
D&A For EBITDA | 7,491 | 7,498 | 7,526 | 6,626 | 6,130 | 6,063 | Upgrade |
EBIT | 30,501 | 29,261 | 25,724 | 21,400 | 17,693 | 18,228 | Upgrade |
EBIT Margin | 25.77% | 25.41% | 23.98% | 22.25% | 20.80% | 22.77% | Upgrade |
Effective Tax Rate | 27.32% | 28.49% | 29.58% | 32.59% | 36.60% | 17.98% | Upgrade |
Revenue as Reported | 117,974 | 115,394 | 107,858 | 96,653 | 87,046 | 80,615 | Upgrade |
Updated Jan 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.